IL15RA and neoplasm: The construction of J100D, demonstrated to produce soluble, bioactive mIL-15/IL-15Rα complex enables the investigation of combinatorial anti-tumor approaches using oHSV and mIL-15/IL-15Rα in multiple cancer models.